Bone Biologics (BBLG) Competitors $2.20 +0.03 (+1.38%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.20 +0.00 (+0.23%) As of 08/22/2025 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BBLG vs. PTHL, QNRX, CHEK, NDRA, TIVC, VERO, AEMD, GCTK, XAGE, and LGMKShould you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include Pheton (PTHL), Quoin Pharmaceuticals (QNRX), Check-Cap (CHEK), ENDRA Life Sciences (NDRA), Tivic Health Systems (TIVC), Venus Concept (VERO), Aethlon Medical (AEMD), GlucoTrack (GCTK), Longevity Health (XAGE), and LogicMark (LGMK). These companies are all part of the "medical equipment" industry. Bone Biologics vs. Its Competitors Pheton Quoin Pharmaceuticals Check-Cap ENDRA Life Sciences Tivic Health Systems Venus Concept Aethlon Medical GlucoTrack Longevity Health LogicMark Pheton (NASDAQ:PTHL) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations. Which has higher earnings and valuation, PTHL or BBLG? Pheton has higher revenue and earnings than Bone Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPheton$448.20K8.81-$660KN/AN/ABone BiologicsN/AN/A-$4.11MN/AN/A Does the media prefer PTHL or BBLG? In the previous week, Pheton had 3 more articles in the media than Bone Biologics. MarketBeat recorded 3 mentions for Pheton and 0 mentions for Bone Biologics. Bone Biologics' average media sentiment score of 0.00 beat Pheton's score of -0.74 indicating that Bone Biologics is being referred to more favorably in the news media. Company Overall Sentiment Pheton Negative Bone Biologics Neutral Do insiders & institutionals believe in PTHL or BBLG? 34.3% of Bone Biologics shares are held by institutional investors. 6.1% of Bone Biologics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is PTHL or BBLG more profitable? Pheton's return on equity of 0.00% beat Bone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets PhetonN/A N/A N/A Bone Biologics N/A -100.58%-93.31% SummaryPheton beats Bone Biologics on 5 of the 8 factors compared between the two stocks. Get Bone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBLG vs. The Competition Export to ExcelMetricBone BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.90M$3.11B$5.75B$9.62BDividend YieldN/A2.23%4.40%4.10%P/E RatioN/A21.2831.3026.05Price / SalesN/A345.81432.98193.75Price / CashN/A43.1937.7358.48Price / Book0.608.129.536.61Net Income-$4.11M-$54.72M$3.26B$265.65M7 Day PerformanceN/A2.62%2.13%2.02%1 Month Performance-28.10%2.68%2.80%-0.31%1 Year Performance-76.94%10.93%30.68%19.06% Bone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBLGBone Biologics0.7279 of 5 stars$2.20+1.4%N/A-75.2%$3.90MN/A0.002Short Interest ↓PTHLPhetonN/A$0.58-10.9%N/AN/A$4.25M$450K0.0011Gap DownQNRXQuoin Pharmaceuticals0.8148 of 5 stars$7.21+0.8%N/A-65.9%$4.21MN/A-0.174CHEKCheck-Cap0.6332 of 5 stars$0.66-0.9%N/A-65.4%$3.87MN/A-0.2280Short Interest ↑NDRAENDRA Life Sciences2.2902 of 5 stars$4.64-3.7%$50.00+977.6%-71.8%$3.63MN/A-0.1420TIVCTivic Health Systems0.4188 of 5 stars$3.05-7.9%N/A-45.4%$3.58M$780K0.0010Short Interest ↑Gap DownVEROVenus Concept0.3736 of 5 stars$2.40+3.4%N/A-61.9%$3.30M$64.83M-0.05410News CoverageAEMDAethlon Medical2.6155 of 5 stars$1.13-3.4%$56.00+4,855.8%-61.2%$3.04M$570K-0.0910Analyst RevisionGap DownGCTKGlucoTrack0.1909 of 5 stars$5.37-6.1%N/A-99.8%$2.73MN/A-0.095XAGELongevity HealthN/A$2.58+5.3%N/AN/A$2.46M$50K0.0014Gap DownLGMKLogicMark0.5225 of 5 stars$0.00-2.6%N/A-99.9%$2.19M$9.88M0.0020Analyst RevisionGap Up Related Companies and Tools Related Companies PTHL Alternatives QNRX Alternatives CHEK Alternatives NDRA Alternatives TIVC Alternatives VERO Alternatives AEMD Alternatives GCTK Alternatives XAGE Alternatives LGMK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBLG) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access